ArticleFrontiers in aging neuroscience2025
Relationship between executive function and dual-task walking in people with Parkinson's disease.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cognitive impairment may present early in people with Parkinson's disease (PwPD), with deficits in executive function potentially impacting gait performance. Previous studies have investigated the association between dual-task walking and executive function in PwPD; however, the results were inconsistent, and the correlation between dual-task walking and subdomains of executive function has not been explored. This study aims to examine the correlation between dual-task walking and subdomains of executive function in PD and assess the predictive power of different subdomains of executive function on dual-task walking performance. Methods: This cross-sectional study included 30 PwPD. Gait was assessed under single-task walking, cognitive dual-task walking, and motor dual-task walking conditions. Executive function was evaluated using the Trail Making Test (TMT), Stroop Color and Word Test (SCWT), and Digit Span Test (DST). Correlation analyses (Pearson or Spearman, as appropriate) and linear regression analyses were used to examine the contribution of executive function subdomains to gait variables that showed significant correlations. Results: Walking speeds under both dual-task conditions were moderately correlated with performance on the TMT Part A and the SCWT. In contrast, stride length during dual-task walking showed broader associations, demonstrating significant correlations with multiple executive function measures. Stepwise linear regression analysis revealed that the SCWT was the only significant predictor of walking speed under both dual-task conditions. For stride length during cognitive dual-task walking, the SCWT remained a significant predictor, while in the motor dual-task condition, both the SCWT and the Forward DST contributed significantly. Specifically, two regression models were significant for stride length during motor dual-task walking: Model 1 included only the SCWT, while Model 2 incorporated both the SCWT and Forward DST. Among dual-task cost outcomes, only the cost of stride length during cognitive dual-task walking was significantly correlated with TMT Part A; however, this association did not remain significant in subsequent regression analyses. Conclusion: This study indicates that, among various executive function assessments, the SCWT shows the strongest correlation with dual-task gait performance in PwPD. This suggests that inhibitory control plays a key role in regulating dual-task walking in individuals with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.